LJCM
GILD icon

Lee Johnson Capital Management’s Gilead Sciences GILD Stock Holding History

Lee Johnson Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,093
Closed -$849K – 87
2026
Q1 		$849K Sell
6,093
-15,729
-72% -$2.2M 0.3% 46
2025
Q4 		$2.68M Sell
21,822
-784
-3% -$95.3K 0.92% 30
2025
Q3 		$2.51M Buy
+22,606
New +$2.57M 0.83% 33

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lee Johnson Capital Management's GILD Position: Q2 2026 in Review

Lee Johnson Capital Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 6,093 shares — an estimated $849K sold.

Lee Johnson Capital Management first reported a position in GILD in Q3 2025 and held it in 3 quarters. The position peaked at $2.68M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lee Johnson Capital Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Lee Johnson Capital Management sold 6,093 Gilead Sciences shares in Q2 2026, an estimated $849K.
  • Lee Johnson Capital Management first reported a position in Gilead Sciences in Q3 2025 and held it in 3 quarters.
  • Lee Johnson Capital Management's Gilead Sciences position peaked at $2.68M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lee Johnson Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.